Lanzul S

Lansoprazole, the active ingredient in Lanzul S, is a proton pump inhibitor presented as a tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and Helicobacter pylori infection in adults.

GNH USA supplies Lanzul S as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor used to reduce gastric acid production in several acid‑related conditions.

- Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication: used in combination therapy to improve eradication rates. - Erosive oesophagitis: promotes mucosal healing and symptom relief.

Lansoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may improve with continued therapy. - Nausea: feeling of queasiness, sometimes accompanied by mild stomach upset. - Abdominal pain: discomfort or cramping in the upper abdomen.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling of face or throat. - Clostridioides difficile‑associated diarrhea: persistent watery stools with abdominal pain. - Interstitial nephritis: inflammation of kidney tissue that may affect renal function.

When prescribing or dispensing Lanzul S, consider the following safety measures.

- Assess renal function: adjust use in patients with severe renal impairment. - Avoid concomitant use with contraindicated drugs: e.g., atazanavir may have reduced absorption. - Monitor magnesium levels during long‑term therapy: risk of hypomagnesemia. - Use with caution in hepatic disease: dose may need adjustment. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Lanzul S can interact with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir (and other protease inhibitors): decreased antiviral absorption, compromising efficacy. - Warfarin: potential increase in INR, requiring closer coagulation monitoring.

Moderate Interactions (Monitor Closely): - Digoxin: possible increase in serum digoxin levels, monitor for toxicity. - Methotrexate: reduced renal clearance may raise methotrexate concentrations, monitor renal function and drug levels.